Published in Nat Med on August 02, 2009
Performance Evaluation of the Bio-Rad Geenius HIV1/2 Supplemental Assay | NCT02401555
Estimating the rate of intersubtype recombination in early HIV-1 group M strains. J Virol (2012) 12.78
Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS (2011) 6.26
Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med (2011) 2.98
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Res (2009) 2.03
Studies of endogenous retroviruses reveal a continuing evolutionary saga. Nat Rev Microbiol (2012) 1.94
The evolution of HIV-1 and the origin of AIDS. Philos Trans R Soc Lond B Biol Sci (2010) 1.54
Universal amplification, next-generation sequencing, and assembly of HIV-1 genomes. J Clin Microbiol (2012) 1.45
Molecular epidemiology of simian immunodeficiency virus infection in wild-living gorillas. J Virol (2009) 1.42
Comparison of HIV-1 RNA measurements obtained by using plasma and dried blood spots in the automated abbott real-time viral load assay. J Clin Microbiol (2011) 1.42
Frequent and recent human acquisition of simian foamy viruses through apes' bites in central Africa. PLoS Pathog (2011) 1.39
Confirmation of putative HIV-1 group P in Cameroon. J Virol (2010) 1.36
HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics. Retrovirology (2013) 1.30
Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections. J Clin Microbiol (2010) 1.28
HIV-1 Group P is unable to antagonize human tetherin by Vpu, Env or Nef. Retrovirology (2011) 1.18
Lack of adaptation to human tetherin in HIV-1 group O and P. Retrovirology (2011) 1.14
Eastern chimpanzees, but not bonobos, represent a simian immunodeficiency virus reservoir. J Virol (2012) 1.13
The biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus. Retrovirology (2012) 1.10
HIV-1 Genetic Variability and Clinical Implications. ISRN Microbiol (2013) 1.10
Immunovirological analyses of chronically simian immunodeficiency virus SIVmnd-1- and SIVmnd-2-infected mandrills (Mandrillus sphinx). J Virol (2011) 1.09
Counteraction of the multifunctional restriction factor tetherin. Front Microbiol (2014) 1.09
Origin of the HIV-1 group O epidemic in western lowland gorillas. Proc Natl Acad Sci U S A (2015) 1.08
Human tetherin exerts strong selection pressure on the HIV-1 group N Vpu protein. PLoS Pathog (2012) 1.08
High prevalence, coinfection rate, and genetic diversity of retroviruses in wild red colobus monkeys (Piliocolobus badius badius) in Tai National Park, Cote d'Ivoire. J Virol (2010) 1.08
Non-M variants of human immunodeficiency virus type 1. Clin Microbiol Rev (2013) 1.05
Mucosal simian immunodeficiency virus transmission in African green monkeys: susceptibility to infection is proportional to target cell availability at mucosal sites. J Virol (2012) 1.04
A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1. PLoS One (2011) 1.04
High GUD incidence in the early 20 century created a particularly permissive time window for the origin and initial spread of epidemic HIV strains. PLoS One (2010) 1.03
Novel multiplexed HIV/simian immunodeficiency virus antibody detection assay. Emerg Infect Dis (2011) 1.02
Characterization of partial and near full-length genomes of HIV-1 strains sampled from recently infected individuals in São Paulo, Brazil. PLoS One (2011) 1.02
Animal virus discovery: improving animal health, understanding zoonoses, and opportunities for vaccine development. Curr Opin Virol (2012) 1.01
Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitors. J Virol (2010) 1.01
Autocatalytic maturation, physical/chemical properties, and crystal structure of group N HIV-1 protease: relevance to drug resistance. Protein Sci (2010) 1.01
Genome Sequences of a Novel HIV-1 Circulating Recombinant Form (CRF59_01B) Identified among Men Who Have Sex with Men in Northeastern China. Genome Announc (2013) 1.01
The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways. J Virol (2010) 0.99
Nef proteins of epidemic HIV-1 group O strains antagonize human tetherin. Cell Host Microbe (2014) 0.99
Evidence for continuing cross-species transmission of SIVsmm to humans: characterization of a new HIV-2 lineage in rural Côte d'Ivoire. AIDS (2013) 0.99
Identification and genetic characterization of a novel CRF22_01A1 recombinant form of HIV type 1 in Cameroon. AIDS Res Hum Retroviruses (2010) 0.99
Recombination pattern reanalysis of some HIV-1 circulating recombination forms suggest the necessity and difficulty of revision. PLoS One (2014) 0.97
Development of a contemporary globally diverse HIV viral panel by the EQAPOL program. J Immunol Methods (2014) 0.97
Emergence of a novel and highly divergent HTLV-3 in a primate hunter in Cameroon. Virology (2010) 0.97
HIV Genetic Diversity and Drug Resistance. Viruses (2010) 0.96
Efficient SIVcpz replication in human lymphoid tissue requires viral matrix protein adaptation. J Clin Invest (2012) 0.95
Large-scale analysis of the prevalence and geographic distribution of HIV-1 non-B variants in the United States. J Clin Microbiol (2013) 0.95
Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon. Virol J (2011) 0.95
The evolution of HIV: inferences using phylogenetics. Mol Phylogenet Evol (2011) 0.94
Factors associated with siman immunodeficiency virus transmission in a natural African nonhuman primate host in the wild. J Virol (2014) 0.94
No evidence for transmission of SIVwrc from western red colobus monkeys (Piliocolobus badius badius) to wild West African chimpanzees (Pan troglodytes verus) despite high exposure through hunting. BMC Microbiol (2011) 0.93
New STLV-3 strains and a divergent SIVmus strain identified in non-human primate bushmeat in Gabon. Retrovirology (2012) 0.92
HIV type 1 pol gene diversity and genotypic antiretroviral drug resistance mutations in Malabo, Equatorial Guinea. AIDS Res Hum Retroviruses (2010) 0.92
Origin and diversity of human retroviruses. AIDS Rev (2014) 0.92
The presence of a vpu gene and the lack of Nef-mediated downmodulation of T cell receptor-CD3 are not always linked in primate lentiviruses. J Virol (2010) 0.91
HIVsirDB: a database of HIV inhibiting siRNAs. PLoS One (2011) 0.91
Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIV-infected patients (CoRIS) are due to recombinant viruses. J Clin Microbiol (2011) 0.90
Tetherin can restrict cell-free and cell-cell transmission of HIV from primary macrophages to T cells. PLoS Pathog (2014) 0.90
Characterization and frequency of a newly identified HIV-1 BF1 intersubtype circulating recombinant form in São Paulo, Brazil. Virol J (2010) 0.89
Noninvasive follow-up of simian immunodeficiency virus infection in wild-living nonhabituated western lowland gorillas in Cameroon. J Virol (2012) 0.89
Molecular epidemiology of HIV-1 clades in Southern Brazil. Mem Inst Oswaldo Cruz (2010) 0.89
Molecular surveillance of HIV-1 in Madrid, Spain: a phylogeographic analysis. J Virol (2011) 0.89
A mechanistic understanding of allosteric immune escape pathways in the HIV-1 envelope glycoprotein. PLoS Comput Biol (2013) 0.88
Vif proteins from diverse primate lentiviral lineages use the same binding site in APOBEC3G. J Virol (2013) 0.88
Current Scenario of HIV/AIDS, Treatment Options, and Major Challenges with Compliance to Antiretroviral Therapy. Cureus (2016) 0.87
The HIV-1 pandemic: does the selective sweep in chimpanzees mirror humankind's future? Retrovirology (2013) 0.87
HIV-1 subtypes and recombinants in Northern Tanzania: distribution of viral quasispecies. PLoS One (2012) 0.87
A gorilla reservoir for human T-lymphotropic virus type 4. Emerg Microbes Infect (2014) 0.87
Ten years of external quality assessment of human immunodeficiency virus type 1 RNA quantification. J Clin Microbiol (2012) 0.87
Performance evaluation of a new fourth-generation HIV combination antigen-antibody assay. Med Microbiol Immunol (2012) 0.87
Heterogeneous susceptibility of circulating SIV isolate capsids to HIV-interacting factors. Retrovirology (2013) 0.87
Identification and characterization of a novel HIV-1 circulating recombinant form (CRF59_01B) identified among men-who-have-sex-with-men in China. PLoS One (2014) 0.86
Current progress in the development of a prophylactic vaccine for HIV-1. Drug Des Devel Ther (2010) 0.85
Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors. Viruses (2014) 0.85
Multiple barriers to recombination between divergent HIV-1 variants revealed by a dual-marker recombination assay. J Mol Biol (2011) 0.85
Delineation of the preferences and requirements of the human immunodeficiency virus type 1 dimerization initiation signal by using an in vivo cell-based selection approach. J Virol (2010) 0.84
Immunopathogenesis of simian immunodeficiency virus infection in nonhuman primates. Curr Opin HIV AIDS (2013) 0.84
Increasing HIV subtype diversity and its clinical implications in a sentinel North American population. Can J Infect Dis Med Microbiol (2013) 0.82
Enhanced detection of viral diversity using partial and near full-length genomes of human immunodeficiency virus Type 1 provirus deep sequencing data from recently infected donors at four blood centers in Brazil. Transfusion (2014) 0.82
Single real-time reverse transcription-PCR assay for detection and quantification of genetically diverse HIV-1, SIVcpz, and SIVgor strains. J Clin Microbiol (2012) 0.82
Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration. PLoS Pathog (2015) 0.82
Polyvalent AIDS vaccines. Curr HIV Res (2010) 0.82
Enhanced heterosexual transmission hypothesis for the origin of pandemic HIV-1. Viruses (2012) 0.82
Connection subdomain mutations in HIV-1 subtype-C treatment-experienced patients enhance NRTI and NNRTI drug resistance. Virology (2012) 0.82
Different frequencies of drug resistance mutations among HIV-1 subtypes circulating in China: a comprehensive study. PLoS One (2014) 0.82
Challenges in the design of a T cell vaccine in the context of HIV-1 diversity. Viruses (2014) 0.81
A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection. J Clin Microbiol (2011) 0.81
Effect of HIV-1 subtypes on disease progression in rural Uganda: a prospective clinical cohort study. PLoS One (2013) 0.81
Utility of Metagenomic Next-Generation Sequencing for Characterization of HIV and Human Pegivirus Diversity. PLoS One (2015) 0.81
The Use of Bioinformatics for Studying HIV Evolutionary and Epidemiological History in South America. AIDS Res Treat (2011) 0.81
The threshold bootstrap clustering: a new approach to find families or transmission clusters within molecular quasispecies. PLoS One (2010) 0.80
Molecular typing of the recently expanding subtype B HIV-1 epidemic in Romania: evidence for local spread among MSMs in Bucharest area. Infect Genet Evol (2012) 0.80
Genetic correlates influencing immunopathogenesis of HIV infection. Indian J Med Res (2011) 0.80
Conflicting selection pressures on T-cell epitopes in HIV-1 subtype B. Infect Genet Evol (2011) 0.80
HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges. Infect Genet Evol (2015) 0.80
Breaking Barriers to an AIDS Model with Macaque-Tropic HIV-1 Derivatives. Biology (Basel) (2012) 0.80
Comparison of the specificities of IgG, IgG-subclass, IgA and IgM reactivities in African and European HIV-infected individuals with an HIV-1 clade C proteome-based array. PLoS One (2015) 0.79
Coreceptor and cytokine concentrations may not explain differences in disease progression observed in HIV-1 clade A and D infected Ugandans. PLoS One (2011) 0.78
New strain of simian immunodeficiency virus identified in wild-born chimpanzees from central Africa. PLoS One (2012) 0.78
Recombinant viruses initiated the early HIV-1 epidemic in Burkina Faso. PLoS One (2014) 0.78
Detailed molecular epidemiologic characterization of HIV-1 infection in Bulgaria reveals broad diversity and evolving phylodynamics. PLoS One (2013) 0.78
Mechanism of dissociative inhibition of HIV protease and its autoprocessing from a precursor. J Mol Biol (2012) 0.78
Novel multiregion hybridization assay for the identification of the most prevalent genetic forms of the human immunodeficiency virus type 1 circulating in Portugal. AIDS Res Hum Retroviruses (2012) 0.78
CRF22_01A1 is involved in the emergence of new HIV-1 recombinants in Cameroon. J Acquir Immune Defic Syndr (2012) 0.78
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature (1999) 10.97
Chimpanzee reservoirs of pandemic and nonpandemic HIV-1. Science (2006) 7.12
HIV-1 nomenclature proposal. Science (2000) 6.61
Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med (1998) 4.92
Human immunodeficiency viruses: SIV infection in wild gorillas. Nature (2006) 3.35
Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J Acquir Immune Defic Syndr (2007) 2.72
Adaptation of HIV-1 to its human host. Mol Biol Evol (2007) 1.77
Origin and biology of simian immunodeficiency virus in wild-living western gorillas. J Virol (2008) 1.76
Virologic diagnosis and follow-up of children born to mothers infected by HIV-1 group O. J Acquir Immune Defic Syndr (2004) 1.14
The molecular population genetics of HIV-1 group O. Genetics (2004) 4.53
Modest public health impact of nontargeted human immunodeficiency virus screening in 29 emergency departments. Arch Intern Med (2011) 4.03
Antiinflammatory profiles during primary SIV infection in African green monkeys are associated with protection against AIDS. J Clin Invest (2005) 3.08
Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr (2007) 2.89
Impact of HIV-1 genetic diversity on plasma HIV-1 RNA Quantification: usefulness of the Agence Nationale de Recherches sur le SIDA second-generation long terminal repeat-based real-time reverse transcriptase polymerase chain reaction test. J Acquir Immune Defic Syndr (2007) 2.72
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature. Nat Genet (2012) 2.63
Protein kinase cδ deficiency causes mendelian systemic lupus erythematosus with B cell-defective apoptosis and hyperproliferation. Arthritis Rheum (2013) 2.60
The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection. J Virol (2009) 2.57
Detection of low-frequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing. AIDS (2009) 2.55
Rapid Diagnosis of Infection in the Critically Ill, a Multicenter Study of Molecular Detection in Bloodstream Infections, Pneumonia, and Sterile Site Infections. Crit Care Med (2015) 2.37
Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS One (2010) 2.10
A paradigm shift in the delivery of services for diagnosis of inherited retinal disease. J Med Genet (2012) 2.09
Mutations in CTC1, encoding conserved telomere maintenance component 1, cause Coats plus. Nat Genet (2012) 1.82
Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification. AIDS Res Hum Retroviruses (2004) 1.73
Field evaluation of a rapid human immunodeficiency virus (HIV) serial serologic testing algorithm for diagnosis and differentiation of HIV type 1 (HIV-1), HIV-2, and dual HIV-1-HIV-2 infections in West African pregnant women. J Clin Microbiol (2004) 1.73
Protein-protein interaction networks and biology--what's the connection? Nat Biotechnol (2008) 1.69
Molecular epidemiology of simian immunodeficiency virus SIVsm in U.S. primate centers unravels the origin of SIVmac and SIVstm. J Virol (2005) 1.66
Genome-wide classification and evolutionary analysis of the bHLH family of transcription factors in Arabidopsis, poplar, rice, moss, and algae. Plant Physiol (2010) 1.66
The distribution of HIV-1 recombination breakpoints. Infect Genet Evol (2007) 1.65
Crimean-Congo hemorrhagic fever, Mauritania. Emerg Infect Dis (2004) 1.65
Cataloguing the HIV type 1 human protein interaction network. AIDS Res Hum Retroviruses (2008) 1.61
Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes. J Virol (2004) 1.61
Convergent evolution of gene networks by single-gene duplications in higher eukaryotes. EMBO Rep (2004) 1.59
Analysis of high-depth sequence data for studying viral diversity: a comparison of next generation sequencing platforms using Segminator II. BMC Bioinformatics (2012) 1.59
Twelve months of routine HIV screening in 6 emergency departments in the Paris area: results from the ANRS URDEP study. PLoS One (2012) 1.56
Rift Valley fever outbreak with East-Central African virus lineage in Mauritania, 2003. Emerg Infect Dis (2007) 1.53
The history of SIVS and AIDS: epidemiology, phylogeny and biology of isolates from naturally SIV infected non-human primates (NHP) in Africa. Front Biosci (2004) 1.53
Foscarnet as salvage therapy in HIV-2-infected patient with antiretroviral treatment failure. J Clin Virol (2009) 1.51
Interleukin-2 before antiretroviral therapy in patients with HIV infection: a randomized trial (ANRS 119). J Infect Dis (2009) 1.49
Impact of viral factors on very early in vivo replication profiles in simian immunodeficiency virus SIVagm-infected African green monkeys. J Virol (2005) 1.48
The evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time--an ultra-deep approach. PLoS Comput Biol (2010) 1.48
Differences in proviral DNA load between HIV-1- and HIV-2-infected patients. AIDS (2008) 1.48
A new quantitative HIV load assay based on plasma virion reverse transcriptase activity for the different types, groups and subtypes. AIDS (2003) 1.45
Molecular mechanisms of recombination restriction in the envelope gene of the human immunodeficiency virus. PLoS Pathog (2009) 1.45
Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breast-feeding. J Virol (2008) 1.44
Undiagnosed HIV prevalence based on nontargeted screening in emergency departments. AIDS (2012) 1.44
Choose your partners: dimerization in eukaryotic transcription factors. Trends Biochem Sci (2008) 1.43
Identifying the important HIV-1 recombination breakpoints. PLoS Comput Biol (2008) 1.42
All duplicates are not equal: the difference between small-scale and genome duplication. Genome Biol (2007) 1.41
Factors associated with clinical progression in HIV-2 infected-patients: the French ANRS cohort. AIDS (2003) 1.40
Specificity in protein interactions and its relationship with sequence diversity and coevolution. Proc Natl Acad Sci U S A (2007) 1.39
On the origins of the extracellular matrix in vertebrates. Matrix Biol (2006) 1.35
Plasma RNA viral load in human immunodeficiency virus type 2 subtype A and subtype B infections. J Clin Microbiol (2002) 1.32
An integrated view of molecular coevolution in protein-protein interactions. Mol Biol Evol (2010) 1.32
Questioning the evidence for genetic recombination in the 1918 "Spanish flu" virus. Science (2002) 1.30
In vitro phenotypic susceptibility of human immunodeficiency virus type 2 clinical isolates to protease inhibitors. Antimicrob Agents Chemother (2008) 1.30
Polyomaviruses KI and WU in immunocompromised patients with respiratory disease. Emerg Infect Dis (2009) 1.29
The integrins of the urochordate Ciona intestinalis provide novel insights into the molecular evolution of the vertebrate integrin family. BMC Evol Biol (2005) 1.23
HIV-1 resistance genotyping on dried serum spots. AIDS (2005) 1.23
Use of four next-generation sequencing platforms to determine HIV-1 coreceptor tropism. PLoS One (2012) 1.21
CD4 cell recovery in treated HIV-2-infected adults is lower than expected: results from the French ANRS CO5 HIV-2 cohort. AIDS (2006) 1.19
Detection of extensive cross-neutralization between pandemic and seasonal A/H1N1 Influenza Viruses using a pseudotype neutralization assay. PLoS One (2010) 1.18
Reconstruction of ancestral protein interaction networks for the bZIP transcription factors. Proc Natl Acad Sci U S A (2007) 1.18
Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays. J Acquir Immune Defic Syndr (2011) 1.17
Defining the role of essential genes in human disease. PLoS One (2011) 1.17
HIV-host interactions: a map of viral perturbation of the host system. AIDS (2009) 1.16
Virologic diagnosis and follow-up of children born to mothers infected by HIV-1 group O. J Acquir Immune Defic Syndr (2004) 1.14
High frequency of selection of K65R and Q151M mutations in HIV-2 infected patients receiving nucleoside reverse transcriptase inhibitors containing regimen. J Med Virol (2004) 1.14
Primary simian immunodeficiency virus SIVmnd-2 infection in mandrills (Mandrillus sphinx). J Virol (2006) 1.13
Characterization and comparison of recombinant simian immunodeficiency virus from drill (Mandrillus leucophaeus) and mandrill (Mandrillus sphinx) isolates. J Virol (2003) 1.13
Patterns of HIV-1 protein interaction identify perturbed host-cellular subsystems. PLoS Comput Biol (2010) 1.11
Detection and partial characterization of simian immunodeficiency virus SIVsm strains from bush meat samples from rural Sierra Leone. J Virol (2005) 1.11
Kuru experiments triggered the emergence of pathogenic SIVmac. AIDS (2006) 1.11
Fully automated quantification of cytomegalovirus (CMV) in whole blood with the new sensitive Abbott RealTime CMV assay in the era of the CMV international standard. J Clin Microbiol (2013) 1.08
Impact of antiretroviral treatment on the tropism of HIV-1 plasma virus populations. AIDS (2003) 1.08
bioNerDS: exploring bioinformatics' database and software use through literature mining. BMC Bioinformatics (2013) 1.08
Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen. AIDS (2008) 1.08
Identification of hepatitis B virus subgenotype A3 in rural Gabon. J Med Virol (2006) 1.08
Sensitive deep-sequencing-based HIV-1 genotyping assay to simultaneously determine susceptibility to protease, reverse transcriptase, integrase, and maturation inhibitors, as well as HIV-1 coreceptor tropism. Antimicrob Agents Chemother (2014) 1.08
Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France. AIDS (2008) 1.07
Methodology capture: discriminating between the "best" and the rest of community practice. BMC Bioinformatics (2008) 1.06
Non-M variants of human immunodeficiency virus type 1. Clin Microbiol Rev (2013) 1.05
SIVagm infection in wild African green monkeys from South Africa: epidemiology, natural history, and evolutionary considerations. PLoS Pathog (2013) 1.05
Diagnosis and monitoring of HIV-1 group O-infected patients in Cameroun. J Acquir Immune Defic Syndr (2010) 1.05
G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to raltegravir whereas Y143C does not. Retrovirology (2011) 1.03
Phenotypic susceptibility to nonnucleoside inhibitors of virion-associated reverse transcriptase from different HIV types and groups. J Acquir Immune Defic Syndr (2004) 1.03
Sensitivity of 8 CE (European Community)-approved rapid disposable tests for anti-HIV antibody detection during and after seroconversion. J Virol Methods (2009) 1.03
Sequence determinants of breakpoint location during HIV-1 intersubtype recombination. Nucleic Acids Res (2006) 1.02
The evolution of the vertebrate metzincins; insights from Ciona intestinalis and Danio rerio. BMC Evol Biol (2007) 1.02
Plasma virion reverse transcriptase activity and heat dissociation-boosted p24 assay for HIV load in Burkina Faso, West Africa. AIDS (2005) 1.02
JC virus variant associated with cerebellar atrophy in a patient with AIDS. J Clin Microbiol (2011) 1.02
Molecular epidemiology of hepatitis B virus in Dakar, Sénégal. J Med Virol (2006) 1.02